The reduction in price target by a prominent analyst like Jessica Fye from JP Morgan is likely to negatively impact investor sentiment towards BioNTech (BNTX) in the short term. An Underweight rating suggests that the analyst believes the stock will underperform its sector or the market, which could lead to a decrease in stock price.